APA (7th ed.) Citation

Méndez-García, L. A., Trejo-Millán, F., Martínez-Reyes, C. P., Manjarrez-Reyna, A. N., Esquivel-Velázquez, M., Melendez-Mier, G., . . . Escobedo, G. (2018). Infliximab ameliorates tumor necrosis factor-alpha-induced insulin resistance by attenuating PTP1B activation in 3T3L1 adipocytes in vitro. Scandinavian journal of immunology, 88(5), . https://doi.org/10.1111/sji.12716

Chicago Style (17th ed.) Citation

Méndez-García, Lucia A., et al. "Infliximab Ameliorates Tumor Necrosis Factor-alpha-induced Insulin Resistance by Attenuating PTP1B Activation in 3T3L1 Adipocytes in Vitro." Scandinavian Journal of Immunology 88, no. 5 (2018). https://doi.org/10.1111/sji.12716.

MLA (9th ed.) Citation

Méndez-García, Lucia A., et al. "Infliximab Ameliorates Tumor Necrosis Factor-alpha-induced Insulin Resistance by Attenuating PTP1B Activation in 3T3L1 Adipocytes in Vitro." Scandinavian Journal of Immunology, vol. 88, no. 5, 2018, https://doi.org/10.1111/sji.12716.